Private Company CEO Compensation by Valuation & Financing
In September 2022, Fortune used Thelander data to look at CEO compensation by financing and valuation. With the challenging fundraising environment, private companies staying private longer and shifting valuations, we wanted to see how the data has changed. Chart 1 looks at CEO median total cash year-over-year by total financing. Our data shows: Chart 2 looks at CEO median total cash year-over-year by valuation. Compensation by valuation […]
How are Life Science Male and Female CEOs Compensated Differently?
In March 2023, we looked at the gender pay gap for life science CEOs. Almost a year later, we are sharing new data from the Thelander Private Compensation dataset, which looks at the number of female CEOs in life sciences and investigates how the gender pay gap is panning out for privately held life science companies in 2024. […]
Private Company Salary Increases for Staff-Level Employees: 2021–2024
Welcome back to the first Private Company Digest of 2024. Following a successful week at the J.P.Morgan Healthcare Conference, we hosted a women’s event at Tiffany & Co honoring more than 300 women executives and investment professionals. You can find pictures here. This month we are diving deeper into the results from the Salary Increase & Bonus Survey, which […]
How are Salary Increases Impacted by Total Amount of Financing?
In this month’s Thelander Digest, we are excited to give you a peak at some of our findings from the Thelander 2023 Year-End Merit Increase, Option Pool & Bonus Survey. With more than 350 participating companies, the survey was a huge success. We explore how CEO salary increases at private companies are impacted by the total amount […]
What is Venture Debt?
Welcome back to the Thelander Private Company Digest. We have a special November edition with a guest writer, Jonathan Norris, who is a Managing Director at HSBC Innovation Banking. In our newsletter, he clearly explains everything you wanted to know about venture debt financing. We’ll let him break it down for you! 1. What is venture […]
How Does Gender Impact Compensation?
Lately, women in the workforce have been regularly making headlines. We’ve seen topics such as the “number of women in the workforce tops pre-pandemic levels for the first time” and that “more mothers are working than ever before.” Thus, for our October newsletter, we are taking a look at gender compensation data for CEOs. In the […]
What Trends Do We See with Carry Dollars at Work?
A few years ago, we added new questions to the Thelander-PitchBook Investment Firm Compensation Survey to collect data on carry dollars at work. Using this data, we’ll be looking at insights on carry dollars at work and how it has changed since 2021. What is carry dollars at work? It’s defined as the amount of carry you will receive […]
Does Stage of Development Impact Compensation for Biotech Companies?
For our August newsletter, we look at data from biotech companies to see how stage of development impacts compensation for its CEOs. The different stages of development can be categorized into five groups:1) Pre-Clinical 2) First in Man 3) FDA Clinical Trial Phase I 4) FDA Clinical Trial Phase II 5) Commercial Chart 1 shows the median for total cash, founder, and non-founder equity for CEOs […]
Europe vs. USA Compensation
For our July newsletter, in the spirit of the Eurotrip returning for summer, we compared compensation for CEOs and Biologists in Europe and the United States. J.Thelander Consulting surveys globally and all data is reported in USD. Let’s take a look. Our Findings: Thelander data clearly shows that the United States compensates higher for cash and […]
What are the Compensation Trends for Research & Development Positions?
In June’s Thelander Digest, we examine the different trends impacting compensation for research & development (R&D) positions. To do this, we looked at our data on how the median total cash and non-founder shares (non-founder equity) has changed since 2019 for two positions: VP and Director of Research & Development (R&D). In order to keep things consistent, we looked at the […]